Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Lixisenatide did not change eGFR decline, and incidences of hard renal endpoints were too low to be meaningfully analyzed [28]
Tirzepatide can contribute to low blood pressure, particularly in patients taking antihypertensive medications or experiencing dehydration from gastrointestinal side effects
Tirzepatide Results The primary outcome of CV death and first heart failure event occurred in 36 patients (9.9%) in the tirzepatide group and 56 patients (15.3%) in the placebo group, for a hazard ratio of 0.62 (95% CI, 0.41-0.95
Opt for complex carbohydrates and lean proteins to help maintain consistent energy levels
US$ 24.26
US$ 28.88
US$ 26.20
